CIBC Private Wealth Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CIBC Private Wealth Group's CLB Position: Q4 2025 in Review
CIBC Private Wealth Group increased its Core Laboratories (CLB) stake by 42% in Q4 2025, buying an estimated $268 and bringing the position to 61 shares worth $978. The position accounts for ﹤0.01% of the portfolio, ranked #2919.
CIBC Private Wealth Group first reported a position in CLB in Q3 2017 and has held it in 18 quarters since. The position peaked at $928K in Q3 2017. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.
- CIBC Private Wealth Group held 61 shares of Core Laboratories worth $978 as of Q4 2025.
- CIBC Private Wealth Group bought 18 Core Laboratories shares in Q4 2025, an estimated $268.
- Core Laboratories made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2919 holding.
- CIBC Private Wealth Group first reported a position in Core Laboratories in Q3 2017 and has held it in 18 quarters since.
- CIBC Private Wealth Group's Core Laboratories position peaked at $928K in Q3 2017.
- 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.